索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]丁振禹,何耀华.色素沉着绒毛结节性滑膜炎诊治进展[J].国际骨科学杂志,2017,02:79-82.
点击复制

色素沉着绒毛结节性滑膜炎诊治进展(PDF)

《国际骨科学杂志》[ISSN:1673-7083/CN:31-1952/R]

期数:
2017年02期
页码:
79-82
栏目:
综述
出版日期:
2017-05-20

文章信息/Info

Title:
-
作者:
丁振禹; 何耀华
200233, 上海交通大学附属第六人民医院骨科
Author(s):
-
关键词:
色素沉着绒毛结节性滑膜炎;  MRI检查;  病理学;  关节镜手术;  放疗
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-7083.2017.02.004
文献标识码:
-
摘要:
色素沉着绒毛结节性滑膜炎(PVNS)是一种罕见的滑膜组织瘤样增生性疾病,根据病变损害范围分为局限性PVNS(LPVNS)和弥漫性PVNS(DPVNS)。该疾病主要临床症状为缓慢进行性肿胀、疼痛及功能受限,MRI检查对PVNS诊断有重要作用,其特征性表现为T2WI低信号,病理学检查可明确诊断。PVNS主要治疗方法是手术切除病变滑膜,LPVNS手术治疗效果好,而DPVNS由于广泛侵蚀滑膜组织,复发率较高,术后辅助放疗可降低DPVNS复发率。生物靶向治疗为难治性PVNS提供了新的治疗思路。该文就PVNS诊治进展作一综述。
Abstract:
-

参考文献/References

[1] Fiocco U, Sfriso P, Lunardi F, et al. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis[J]. Autoimmun Rev, 2010, 9(11):780-784.
[2] Xie GP, Jiang N, Liang CX, et al. Pigmented villonodular synovitis: a retrospective multicenter study of 237 cases[J]. PLoS One, 2015, 10(3):e0121451.
[3] Li W, Sun X, Lin J, et al. Arthroscopic synovectomy and postoperative assisted radiotherapy for treating diffuse pigmented villonodular synovitis of the knee: an observational retrospective study[J]. Pak J Med Sci, 2015, 31(4):956-960.
[4] Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor(formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)[J]. Orthop Traumatol Surg Res, 2017, 103(1S):S91-S97.
[5] Imakiire N, Fujino T, Morii T, et al. Malignant pigmented villonodular synovitis in the knee-report of a case with rapid clinical progression[J]. Open Orthop J, 2011, 5:13-16.
[6] Righi A, Gambarotti M, Sbaraglia M, et al. Metastasizing tenosynovial giant cell tumour, diffuse type/pigmented villonodularsynovitis[J]. Clin Sarcoma Res, 2015, 5:15.
[7] West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells[J]. Proc Natl Acad Sci USA, 2006, 103(3):690-695.
[8] Brahmi M, Vinceneux A, Cassier PA. Current systemic treatment options for tenosynovial giant cell tumor/pigmented villonodular synovitis: targeting the CSF1/CSF1R axis[J]. Curr Treat Options Oncol, 2016, 17(2):10.
[9] Chen K, Ren Q, Han XR, et al. Imatinibmesylate induces mitochondria-dependent apoptosis and inhibits invasion of human pigmented villonodular synovitis fibroblast-like synovial cells[J]. Oncol Rep, 2016, 35(1):197-204.
[10] Kubat O, Bojanic I, Smoljanovic T. Localized pigmented villonodular synovitis of the ankle: expect the unexpected[J]. Foot Ankle Surg, 2017, 23(1):68-72.
[11] Zhao L, Zhou K, Hua Y, et al. Multifocal pigmented villonodular synovitis in a child: a case report[J]. Medicine(Baltimore), 2016, 95(33):e4572.
[12] Camp CL, Yuan BJ, Wood AJ, et al. Pigmented villonodular synovitis diagnosed during revision total knee arthroplasty for flexion instability and patellar fracture[J]. Knee, 2016, 23(2):338-341.
[13] Lang N, Yuan HS. Computed tomography and magnetic resonance manifestations of spinal pigmented villonodularsynovitis[J]. J Comput Assist Tomogr, 2015, 39(4):601-606.
[14] 陈基明,吴莉莉,翟建,等. 大关节腱鞘巨细胞瘤与色素沉着绒毛结节性滑膜炎的 MRI 特征及其鉴别诊断[J]. 临床放射学杂志, 2015, 34(10):1638-1642.
[15] Murphey MD, Rhee JH, Lewis RB, et al. Pigmented villonodular synovitis: radiologic-pathologic correlation[J]. Radiographics, 2008, 28(5):1493-1518.
[16] Friedman T, Chen T, Chang A. MRI diagnosis of recurrent pigmented villonodular synovitis following total joint arthroplasty[J]. HSS J, 2013, 9(1):100-105.
[17] Kapoor C, Jhaveri M, Soni R, et al. Pigmented villonodular synovitis of the knee joint: a case report[J]. Cureus, 2016, 8(10):e816.
[18] Palmerini E, Staals EL, Maki RG, et al. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors[J]. Eur J Cancer, 2015, 51(2):210-217.
[19] Mahendra G, Kliskey K, Athanasou NA. Immunophenotypic distinction between pigmented villonodular synovitis and haemosideroticsynovitis[J]. J ClinPathol, 2010, 63(1):75-78.
[20] 何耀华,赵金忠,蒋垚,等. 膝关节镜下诊治局灶性色素沉着绒毛结节性滑膜炎的临床疗效[J]. 中华骨科杂志, 2008, 28(11):902-905.
[21] de Visser E, Veth RP, Pruszczynski M, et al. Diffuse and localized pigmented villonodular synovitis: evaluation of treatment of 38 patients[J]. Arch Orthop Trauma Surg, 1999, 119(7-8):401-404.
[22] Ogilvie-Harris DJ, Mclean J, Zarnett ME. Pigmented villonodular synovitis of the knee. The results of total arthroscopic synovectomy, partial, arthroscopic synovectomy, and arthroscopic local excision[J]. J Bone Joint Surg Am, 1992, 74(1):119-123.
[23] Loriaut P, Djian P, Boyer T, et al. Arthroscopic treatment of localized pigmented villonodular synovitis of the knee[J]. Knee Surg Sports Traumatol Arthrosc, 2012, 20(8):1550-1553.
[24] Georgiannos D, Boutsiadis A, Agathangelidis F, et al. Arthroscopically-assisted mini open partial synovectomy for the treatment of localized pigmented villonodular synovitis of the knee. A retrospective comparative study with long-term follow up[J]. Int Orthop, 2016, [Epub ahead of print].
[25] Akinci O, Akalin Y, Incesu M, et al. Long-term results of surgical treatment of pigmented villonodular synovitis of the knee[J]. Acta Orthop Traumatol Turc, 2011, 45(3):149-155.
[26] Chen WM, Wu PK, Liu CL. Simultaneous anterior and posterior synovectomies for treating diffuse pigmented villonodularsynovitis[J]. Clin Orthop Relat Res, 2012, 470(6):1755-1762.
[27] Ravi V, Wang WL, Lewis VO. Treatment of tenosynovial giant cell tumor and pigmented villonodularsynovitis[J]. Curr Opin Oncol, 2011, 23(4):361-366.
[28] Heyd R, Seegenschmiedt MH, Micke O. The role of external beam radiation therapy in the adjuvant treatment of pigmented villonodular synovitis[J]. Z Orthop Unfall, 2011, 149(6):677-682.
[29] Park G, Kim YS, Kim JH, et al. Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee: 4 recurrences in 23 patients followed for mean 9 years[J]. Acta Orthop, 2012, 83(3):256-260.
[30] Mollon B, Lee A, Busse JW, et al. The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis[J]. Bone Joint J, 2015, 97B(4):550-557.
[31] Chin KR, Barr SJ, Winalski C, et al. Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee[J]. J Bone Joint Surg Am, 2002, 84(12):2192-2202.
[32] Bickels J, Isaakov J, Kollender Y, et al. Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis[J]. J Bone Joint Surg Am, 2008, 90(2):326-328.
[33] Stacchiotti S, Crippa F, Messina A, et al. Response to imatinib in villonodular pigmented synovitis(PVNS)resistant to nilotinib[J]. Clin Sarcoma Res, 2013, 3(1):8.
[34] Praino E, Lapadula G, Scioscia C, et al. Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: a case series and review of the literature[J]. Int J Rheum Dis, 2015, 18(8):908-912.

备注/Memo

备注/Memo:
通信作者: 何耀华 E-mail: heyaohua_sh@126.com
更新日期/Last Update: 2017-05-20